U-IPSEY

Q:IPSEY - IPSEN SA SPONS ADR EA REPR 0.25 ORD - Website unknown - click to update

22:06:43 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
IPSEY - Q	not subscribed					28.755	+0.035	0.1	1.3	37	23	28.755 28.755 28.755	34.338 26.97	15:59:39	Apr 02	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market: OTC Markets -- Tier: OTC Pink Limited -- Status: Active

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 23

More trades...

Time ET	Ex	Price	Change	Volume
15:59:39	Q	28.29	-0.43	8
15:06:34	Q	28.62	-0.10	11
15:05:56	Q	28.6763	-0.0437	5
15:02:40	Q	28.686	-0.034	5
14:03:51	Q	28.79	0.07	23
14:01:37	Q	28.62	-0.10	63
13:48:16	Q	28.6662	-0.0538	23
13:46:56	Q	28.62	-0.10	15
13:34:36	Q	28.62	-0.10	4
13:26:37	Q	28.62	-0.10	7

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2024-04-02 07:00	U:IPSEY	News Release200	Marengo Therapeutics Announces First Drug Candidate Nomination from Oncology Collaboration with Ipsen
2023-11-13 07:00	U:IPSEY	News Release200	Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay ™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
2023-11-13 07:00	U:IPSEY	News Release200	Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay ¢ „ ¢ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Date ET

Symbol

Type

Headline

2024-04-02 07:00

U:IPSEY

News Release

Marengo Therapeutics Announces First Drug Candidate Nomination from Oncology Collaboration with Ipsen

2023-11-13 07:00

U:IPSEY

News Release

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay ™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

2023-11-13 07:00

U:IPSEY

News Release

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay ¢ „ ¢ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)